Review
BibTex RIS Cite

Diyabetik maküler ödemde görüntüleme

Year 2018, Volume: 11 Issue: 3, 376 - 382, 25.12.2018
https://doi.org/10.26559/mersinsbd.383987

Abstract



Diyabetik maküler ödem (DMÖ), diyabetik retinopatinin görme
kaybı ile sonuçlanan en önemli komplikasyonlarından biridir. Dünya genelinde,
yılda 100.000’den fazla olguda yasal körlüğe neden olduğu bilinmektedir. Bu
bakımdan ele alındığında hastalık ciddi bir halk sağlığı sorunudur. DMÖ
tanısında standardizasyonun sağlanması, doğru olgularda tedavi kararı verilmesi
hasta kayıtlarında ortak bir dil kullanılması açısından gereklidir. Early
Treatment Diabetic Retinopathy Study (ETDRS) Grubu’nun önerdiği tanı
kriterleri, gelişen görüntüleme yöntemlerinin katkısı ve hastalık hakkındaki
bilgilerimizin daha ilerilere taşınması nedeniyle, bugün için önemini büyük
ölçüde yitirmiştir. Oftalmolojideki teknik gelişmelere paralel, DMÖ tanı ve
takibinde kullanılan yöntemlerdeki gelişim süreklilik arz etmektedir. Fundus
biyomikroskopisi, renkli fundus fotoğraflaması, fundus floresein anjiografi ve
optik koherans tomografi (OKT) klinik pratiğimizde en sık kullandığımız ve
gelenekselleşmiş yöntemlerdir. Fundus otofloresans, mikroperimetri, tarayıcı
laser oftalmoskopi ve OKT ile ölçülen retinal kalınlık haritalamaları yeni
yöntemler olmamalarına rağmen, ilave özelliklerle DMÖ tanı ve takibinde
kendilerine kullanım alanı bulan geleneksel yöntemlerin yeniden yorumlanmış
halleri sayılabilir. Yeni yazılım ve donanım eklentileri ile zenginleştirilen
polarizasyon duyarlı OKT, en face OKT, OKT anjiografi ve adaptif optik
görüntüleme ise muhtemelen DMÖ tanı ve takibinde gelecekte daha çok
kullanılacak olan yeni görüntüleme yöntemleridir. Gerek mevcut az kullanılan
yöntemlerin DMÖ’deki kullanım alanının genişlemesi gerek tanımlanmış yeni
yöntemler, DMÖ ile ilgili bilgilerimizi artırmamız ve daha etkin tedavi
sağlamamıza katkıda bulunacaktır. Bu çalışmada amacımız, DMÖ tanı ve takibinde
kullanılan geleneksel yöntemler, ilave modifikasyonlarla kullanılmaya başlanmış
yöntemler ve yeni görüntüleme yöntemleri hakkında bilgi vermektir. 

References

  • Klein R, Knudtson MD, Lee KE, Gangnon R, Klein B. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115(11):1859-1868.
  • Paulus YM, Gariano RF. Diabetic retinopathy: a growing concern in an aging population. Geriatrics. 2009;64(2):16-20.
  • White NH, Sun W, Cleary PA, Tamborlane WV, Danis RP, Hainsworth DP, et al. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes. 2010;59(5):1244-1253.
  • Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol. 2009;54(1):1-32.
  • Zhang X, Bao S, Lai D, Rapkins RW, Gillies MC. Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes. 2008;57(4):1026-1033.
  • Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha-Vaz J, Ambrosio AF, et al. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2007;48(11):5257-1565.
  • Zhang X, Zeng H, Bao S, Wang N, Gillies MC. Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci. 2014 May 14;4:27.
  • Park HY, Kim JH, Park CK. Neuronal cell death in the inner retina and the influence of vascular endothelial growth factor inhibition in a diabetic rat model. Am J Pathol. 2014;184(6):1752-1762.
  • Omri S, Omri B, Savoldelli M, Jonet L, Thillaye-Goldenberg B, Thuret G, et al. The outer limiting membrane (OLM) revisited: clinical implications. Clin Ophthalmol. 2010 Apr 26;4:183-195.
  • Mackenzie S, Schmermer C, Charnley A, Sim D, Vikas Tah, Dumskiyj M, et al. SDOCT imaging to identify macular pathology in patients diagnosed with diabetic maculopathy by a digital photographic retinal screening programme. PLoS One. 2011;6(5):e14811.
  • Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98(5 Suppl):786-806.
  • Danis RP, Hubbard LD. Imaging of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2011;11(4):236-243.
  • Çıtırık M, İlhan Ç, Teke MY. Optik Koherans Tomography. Güncel Retina. 2017;1(1):58-68.
  • Sikorski BL, Malukiewicz G, Stafiej J, Lesiewska-Junk H, Raczynska D. The diagnostic function of OCT in diabetic maculopathy. Mediators Inflamm. 2013;2013:434560.
  • Yoshitake S, Murakami T, Uji A, Unoki N, Dodo Y, Horli T, et al. Clinical relevance of quantified fundus autofluorescence in diabetic macular oedema. Eye (Lond). 2015;29(5):662-669.
  • Shen Y, Xu X, Liu K. Fundus autofluorescence characteristics in patients with diabetic macular edema. Chin Med J (Engl). 2014;127(8):1423-1428.
  • Midena E, Bini S. Multimodal retinal imaging of diabetic macular edema: toward new paradigms of pathophysiology. Graefes Arch Clin Exp Ophthalmol. 2016;254(9):1661-1668.
  • Midena E, Vujosevic S. Microperimetry in diabetic retinopathy. Saudi J Ophthalmol. 2011;25(2):131–135. 
  • Vujosevic S, Trento B, Bottega E, Urban F, Pilotto E, Midena E. Scanning laser ophthalmoscopy in the retromode in diabetic macular oedema. Acta Ophthalmol. 2012;90(5):374-380.
  • Lammer J, Bolz M, Baumann B, Pircher M, Gerendas B, Schlanitz F, et al. Detection and analysis of hard exudates by polarization-sensitive optical coherence tomography in patients with diabetic maculopathy. Invest Ophthalmol Vis Sci. 2014;55(3):1564-1571.
  • Lee J, Rosen R. Optical Coherence Tomography Angiography in Diabetes. Curr Diab Rep. 2016;16(12):123.
  • Soliman MK, Sadiq MA, Agarwal A, Sarwar S, Hassan M, Hanout M, et al. High-Resolution Imaging of Parafoveal Cones in Different Stages of Diabetic Retinopathy Using Adaptive Optics Fundus Camera. PLoS One. 2016;11(4):e0152788.
Year 2018, Volume: 11 Issue: 3, 376 - 382, 25.12.2018
https://doi.org/10.26559/mersinsbd.383987

Abstract

References

  • Klein R, Knudtson MD, Lee KE, Gangnon R, Klein B. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115(11):1859-1868.
  • Paulus YM, Gariano RF. Diabetic retinopathy: a growing concern in an aging population. Geriatrics. 2009;64(2):16-20.
  • White NH, Sun W, Cleary PA, Tamborlane WV, Danis RP, Hainsworth DP, et al. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes. 2010;59(5):1244-1253.
  • Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol. 2009;54(1):1-32.
  • Zhang X, Bao S, Lai D, Rapkins RW, Gillies MC. Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes. 2008;57(4):1026-1033.
  • Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha-Vaz J, Ambrosio AF, et al. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2007;48(11):5257-1565.
  • Zhang X, Zeng H, Bao S, Wang N, Gillies MC. Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci. 2014 May 14;4:27.
  • Park HY, Kim JH, Park CK. Neuronal cell death in the inner retina and the influence of vascular endothelial growth factor inhibition in a diabetic rat model. Am J Pathol. 2014;184(6):1752-1762.
  • Omri S, Omri B, Savoldelli M, Jonet L, Thillaye-Goldenberg B, Thuret G, et al. The outer limiting membrane (OLM) revisited: clinical implications. Clin Ophthalmol. 2010 Apr 26;4:183-195.
  • Mackenzie S, Schmermer C, Charnley A, Sim D, Vikas Tah, Dumskiyj M, et al. SDOCT imaging to identify macular pathology in patients diagnosed with diabetic maculopathy by a digital photographic retinal screening programme. PLoS One. 2011;6(5):e14811.
  • Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98(5 Suppl):786-806.
  • Danis RP, Hubbard LD. Imaging of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2011;11(4):236-243.
  • Çıtırık M, İlhan Ç, Teke MY. Optik Koherans Tomography. Güncel Retina. 2017;1(1):58-68.
  • Sikorski BL, Malukiewicz G, Stafiej J, Lesiewska-Junk H, Raczynska D. The diagnostic function of OCT in diabetic maculopathy. Mediators Inflamm. 2013;2013:434560.
  • Yoshitake S, Murakami T, Uji A, Unoki N, Dodo Y, Horli T, et al. Clinical relevance of quantified fundus autofluorescence in diabetic macular oedema. Eye (Lond). 2015;29(5):662-669.
  • Shen Y, Xu X, Liu K. Fundus autofluorescence characteristics in patients with diabetic macular edema. Chin Med J (Engl). 2014;127(8):1423-1428.
  • Midena E, Bini S. Multimodal retinal imaging of diabetic macular edema: toward new paradigms of pathophysiology. Graefes Arch Clin Exp Ophthalmol. 2016;254(9):1661-1668.
  • Midena E, Vujosevic S. Microperimetry in diabetic retinopathy. Saudi J Ophthalmol. 2011;25(2):131–135. 
  • Vujosevic S, Trento B, Bottega E, Urban F, Pilotto E, Midena E. Scanning laser ophthalmoscopy in the retromode in diabetic macular oedema. Acta Ophthalmol. 2012;90(5):374-380.
  • Lammer J, Bolz M, Baumann B, Pircher M, Gerendas B, Schlanitz F, et al. Detection and analysis of hard exudates by polarization-sensitive optical coherence tomography in patients with diabetic maculopathy. Invest Ophthalmol Vis Sci. 2014;55(3):1564-1571.
  • Lee J, Rosen R. Optical Coherence Tomography Angiography in Diabetes. Curr Diab Rep. 2016;16(12):123.
  • Soliman MK, Sadiq MA, Agarwal A, Sarwar S, Hassan M, Hanout M, et al. High-Resolution Imaging of Parafoveal Cones in Different Stages of Diabetic Retinopathy Using Adaptive Optics Fundus Camera. PLoS One. 2016;11(4):e0152788.
There are 22 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Articles
Authors

Çağrı İlhan 0000-0001-9122-2466

Publication Date December 25, 2018
Submission Date January 25, 2018
Acceptance Date October 2, 2018
Published in Issue Year 2018 Volume: 11 Issue: 3

Cite

APA İlhan, Ç. (2018). Diyabetik maküler ödemde görüntüleme. Mersin Üniversitesi Sağlık Bilimleri Dergisi, 11(3), 376-382. https://doi.org/10.26559/mersinsbd.383987
AMA İlhan Ç. Diyabetik maküler ödemde görüntüleme. Mersin Univ Saglık Bilim derg. December 2018;11(3):376-382. doi:10.26559/mersinsbd.383987
Chicago İlhan, Çağrı. “Diyabetik maküler ödemde görüntüleme”. Mersin Üniversitesi Sağlık Bilimleri Dergisi 11, no. 3 (December 2018): 376-82. https://doi.org/10.26559/mersinsbd.383987.
EndNote İlhan Ç (December 1, 2018) Diyabetik maküler ödemde görüntüleme. Mersin Üniversitesi Sağlık Bilimleri Dergisi 11 3 376–382.
IEEE Ç. İlhan, “Diyabetik maküler ödemde görüntüleme”, Mersin Univ Saglık Bilim derg, vol. 11, no. 3, pp. 376–382, 2018, doi: 10.26559/mersinsbd.383987.
ISNAD İlhan, Çağrı. “Diyabetik maküler ödemde görüntüleme”. Mersin Üniversitesi Sağlık Bilimleri Dergisi 11/3 (December 2018), 376-382. https://doi.org/10.26559/mersinsbd.383987.
JAMA İlhan Ç. Diyabetik maküler ödemde görüntüleme. Mersin Univ Saglık Bilim derg. 2018;11:376–382.
MLA İlhan, Çağrı. “Diyabetik maküler ödemde görüntüleme”. Mersin Üniversitesi Sağlık Bilimleri Dergisi, vol. 11, no. 3, 2018, pp. 376-82, doi:10.26559/mersinsbd.383987.
Vancouver İlhan Ç. Diyabetik maküler ödemde görüntüleme. Mersin Univ Saglık Bilim derg. 2018;11(3):376-82.

MEU Journal of Health Sciences Assoc was began to the publishing process in 2008 under the supervision of Assoc. Prof. Gönül Aslan, Editor-in-Chief, and affiliated to Mersin University Institute of Health Sciences. In March 2015, Prof. Dr. Caferi Tayyar Şaşmaz undertook the Editor-in Chief position and since then he has been in charge.

Publishing in three issues per year (April - August - December), it is a multisectoral refereed scientific journal. In addition to research articles, scientific articles such as reviews, case reports and letters to the editor are published in the journal. Our journal, which has been published via e-mail since its inception, has been published both online and in print. Following the Participation Agreement signed with TÜBİTAK-ULAKBİM Dergi Park in April 2015, it has started to accept and evaluate online publications.

Mersin University Journal of Health Sciences have been indexed by Turkey Citation Index since November 16, 2011.

Mersin University Journal of Health Sciences have been indexed by ULAKBIM Medical Database from the first issue of 2016.

Mersin University Journal of Health Sciences have been indexed by DOAJ since October 02, 2019.

Article Publishing Charge Policy: Our journal has adopted an open access policy and there is no fee for article application, evaluation, and publication in our journal. All the articles published in our journal can be accessed from the Archive free of charge.

154561545815459

Creative Commons Lisansı
This work is licensed with Attribution-NonCommercial 4.0 International.